Drug Type Small molecule drug |
Synonyms IPG 008, IPG-008, IPG008 + [1] |
Target |
Mechanism Hydrolase inhibitors, NAD+ inhibitors(NAD(Nicotinamide adenine dinucleotide) inhibitors) |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | CN | 15 Mar 2023 | |
Amyotrophic Lateral Sclerosis | Preclinical | CN | 15 Mar 2023 | |
Mitochondrial Myopathies | Preclinical | CN | 15 Mar 2023 |